Katharina John

792 total citations
20 papers, 533 citations indexed

About

Katharina John is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Katharina John has authored 20 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Katharina John's work include Liver Disease Diagnosis and Treatment (7 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and MicroRNA in disease regulation (2 papers). Katharina John is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and MicroRNA in disease regulation (2 papers). Katharina John collaborates with scholars based in Germany, China and United Kingdom. Katharina John's co-authors include Klaus Schulze‐Osthoff, Heike Bantel, Michael P. Manns, David R. Meldrum, Y Erlik, Howard L. Judd, Heike Bantel, Franziska Wandrer, Arndt Vogel and Roland E. Kontermann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Katharina John

16 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharina John Germany 13 182 157 102 99 89 20 533
Lingling Shu China 14 274 1.5× 119 0.8× 125 1.2× 74 0.7× 87 1.0× 35 596
Xiaolin Zhang China 17 209 1.1× 106 0.7× 104 1.0× 75 0.8× 134 1.5× 52 571
Jie Kuang China 12 244 1.3× 160 1.0× 92 0.9× 108 1.1× 46 0.5× 27 614
Kuang‐Tzu Huang Taiwan 14 285 1.6× 95 0.6× 149 1.5× 101 1.0× 52 0.6× 38 528
Laura Antonucci Italy 14 446 2.5× 118 0.8× 120 1.2× 209 2.1× 101 1.1× 21 746
Elisa Manieri Spain 10 292 1.6× 126 0.8× 71 0.7× 186 1.9× 79 0.9× 12 629
Xiaotong Zhao China 15 200 1.1× 105 0.7× 115 1.1× 75 0.8× 36 0.4× 50 520
Carole Ferraro‐Peyret France 13 300 1.6× 90 0.6× 86 0.8× 113 1.1× 118 1.3× 28 673

Countries citing papers authored by Katharina John

Since Specialization
Citations

This map shows the geographic impact of Katharina John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina John more than expected).

Fields of papers citing papers by Katharina John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina John. The network helps show where Katharina John may publish in the future.

Co-authorship network of co-authors of Katharina John

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina John. A scholar is included among the top collaborators of Katharina John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina John. Katharina John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franck, Martin, Katharina John, Monika Rau, et al.. (2025). Limitations of Guideline‐Recommended Risk Stratification in Identifying MASLD Patients for Novel Drug Treatments. Liver International. 45(9). e70281–e70281.
2.
John, Katharina, et al.. (2025). Non-invasive Identification of Metabolic Dysfunction-associated Steatotic Liver Disease Patients Eligible for Resmetirom Treatment. Clinical Gastroenterology and Hepatology. 23(10). 1854–1856.e2.
3.
John, Katharina, Martin Franck, Andreas Geier, et al.. (2025). WED-384 Non-invasive identification of MASLD patients eligible for resmetirom treatment – data from a multicenter biopsy-proven MASLD cohort. Journal of Hepatology. 82. S538–S538.
4.
Franck, Martin, Katharina John, Monika Rau, et al.. (2023). Hepatokine‐based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients. Liver International. 43(12). 2668–2679. 6 indexed citations
5.
Landwehr-Kenzel, Sybille, Niklas Engels, Andrea Schienke, et al.. (2023). Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application. Journal of Autoimmunity. 138. 103057–103057. 35 indexed citations
6.
John, Katharina, Martin Franck, Monika Rau, et al.. (2022). Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4. Journal of Clinical Medicine. 11(15). 4394–4394. 7 indexed citations
7.
Richter, Julia, Katharina John, Annette M. Staiger, et al.. (2021). Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. British Journal of Haematology. 196(3). 681–689. 16 indexed citations
8.
John, Katharina, Franziska Wandrer, Florian W. R. Vondran, et al.. (2021). BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment. Cell Death and Disease. 12(8). 736–736. 12 indexed citations
9.
Richter, Fabian, Sarah K. Williams, Katharina John, et al.. (2021). The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation. Frontiers in Immunology. 12. 705485–705485. 25 indexed citations
10.
Wandrer, Franziska, Živa Frangež, Katharina John, et al.. (2020). Autophagy alleviates amiodarone-induced hepatotoxicity. Archives of Toxicology. 94(10). 3527–3539. 17 indexed citations
11.
Wandrer, Franziska, Silke Marhenke, Arndt Vogel, et al.. (2020). TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death and Disease. 11(3). 212–212. 111 indexed citations
12.
Li, Xiaofei, Lan Liu, Lihui Wang, et al.. (2020). Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells. Journal of International Medical Research. 48(8). 1220745721–1220745721. 25 indexed citations
13.
Li, Xiaofei, Cong Xu, Hui Wu, et al.. (2020). SiRNA targeting PFK1 inhibits proliferation and migration and enhances radiosensitivity by suppressing glycolysis in colorectal cancer.. PubMed. 12(9). 4923–4940. 17 indexed citations
14.
Flanagan, Lorna, M. Meyer, Joanna Fay, et al.. (2016). Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach. Cell Death and Disease. 7(2). e2087–e2087. 90 indexed citations
15.
John, Katharina, et al.. (2015). Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patients. European Journal of Cancer. 51(12). 1596–1602. 8 indexed citations
16.
Wandrer, Franziska, Christine S. Falk, Katharina John, et al.. (2015). Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection. The Journal of Infectious Diseases. 213(5). 746–754. 13 indexed citations
17.
John, Katharina, Johannes Hadem, Till Krech, et al.. (2014). MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology. 60(4). 1346–1355. 74 indexed citations
18.
John, Katharina. (2013). Zwischen Geschichtswissenschaft und Narratologie. Jonas Grethlein und Christopher B. Krebs über die Bedeutung und Komplexität von Zeit und Erzählung in antiken historischen Texten [Jonas Grethlein / Christopher B. Krebs (Hg.): Time and Narrative in Ancient Historiography. The ‘Plupast’ from Herodotus to Appian. Cambridge 2012]. SHILAP Revista de lepidopterología.
19.
John, Katharina, et al.. (2013). Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome. Cell Death and Disease. 4(10). e886–e886. 15 indexed citations
20.
Meldrum, David R., Y Erlik, Katharina John, & Howard L. Judd. (1981). Objectively Recorded Hot Flushes in Patients with Pituitary Insufficiency*. The Journal of Clinical Endocrinology & Metabolism. 52(4). 684–687. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingling Shu Breakdown of academic impact, for papers by Xiaolin Zhang Breakdown of academic impact, for papers by Jie Kuang Breakdown of academic impact, for papers by Kuang‐Tzu Huang Breakdown of academic impact, for papers by Laura Antonucci Breakdown of academic impact, for papers by Elisa Manieri Breakdown of academic impact, for papers by Xiaotong Zhao Breakdown of academic impact, for papers by Carole Ferraro‐Peyret
Rankless by CCL
2026